The company acquired Qutenza, an FDA-approved pain patch for the management of neuropathic pain associated with postherpetic neuralgia. It also acquired NP-1998, a prescription strength capsaicin topical solution, which being assessed for the treatment of neuropathic pain and is ready for phase three of its trial.
More Articles on Pain Management:
Sussex Pain Relief Center Breaks Ground on New Location in Delaware
Florida’s Lake County to Extend Pain Management Clinic Ban
Arizona Pain Specialists Opens New Location
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.